Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R J Hohl

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Bone Marrow Transplantation|August 16, 2002
A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantationC K Lee, M de Magalhaes-Silverman, M Hayashi, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2003
A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheepP Veng-Pedersen, S Chapel, N H Al-Huniti, et al.
Biopharmaceutics & Drug Disposition|April 27, 2004
Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablationP Veng-Pedersen, S Chapel, N H Al-Huniti, et al.
Clinical Pharmacology and Therapeutics|April 13, 2007
Change in erythropoietin pharmacokinetics following hematopoietic transplantationJ A Widness, R L Schmidt, R J Hohl, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1996
Iowa newborn hemoglobinopathy screening and comprehensive care: a model for rural statesC Peters, J Miller, S L Abel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantationC K Lee, R D Gingrich, M deMagalhaes-Silverman, et al.
Bone Marrow Transplantation|March 7, 2003
Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graftC-K Lee, M deMagalhaes-Silverman, R J Hohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473C P Burns, S Halabi, G H Clamon, et al.
Bone Marrow Transplantation|April 30, 2002
Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphomaC-K Lee, M de Magalhaes-Silverman, R J Hohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207J E Rosenberg, S Halabi, B L Sanford, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Bone Marrow Transplantation|August 16, 2002
A dose escalation study for salvage chemotherapy in patients with refractory lymphoma prior to high-dose myeloablative therapy with stem cell transplantationC K Lee, M de Magalhaes-Silverman, M Hayashi, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 17, 2003
A differential pharmacokinetic analysis of the erythropoietin receptor population in newborn and adult sheepP Veng-Pedersen, S Chapel, N H Al-Huniti, et al.
Biopharmaceutics & Drug Disposition|April 27, 2004
Pharmacokinetic tracer kinetics analysis of changes in erythropoietin receptor population in phlebotomy-induced anemia and bone marrow ablationP Veng-Pedersen, S Chapel, N H Al-Huniti, et al.
Clinical Pharmacology and Therapeutics|April 13, 2007
Change in erythropoietin pharmacokinetics following hematopoietic transplantationJ A Widness, R L Schmidt, R J Hohl, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1996
Iowa newborn hemoglobinopathy screening and comprehensive care: a model for rural statesC Peters, J Miller, S L Abel, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|May 8, 1999
Prophylactic reinfusion of T cells for T cell-depleted allogeneic bone marrow transplantationC K Lee, R D Gingrich, M deMagalhaes-Silverman, et al.
Bone Marrow Transplantation|March 7, 2003
Donor T-lymphocyte infusion for unrelated allogeneic bone marrow transplantation with CD3+ T-cell-depleted graftC-K Lee, M deMagalhaes-Silverman, R J Hohl, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 13, 2000
Phase I clinical study of fish oil fatty acid capsules for patients with cancer cachexia: cancer and leukemia group B study 9473C P Burns, S Halabi, G H Clamon, et al.
Bone Marrow Transplantation|April 30, 2002
Prophylactic T cell infusion after T cell-depleted bone marrow transplantation in patients with refractory lymphomaC-K Lee, M de Magalhaes-Silverman, R J Hohl, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 15, 2008
Phase II study of bortezomib in patients with previously treated advanced urothelial tract transitional cell carcinoma: CALGB 90207J E Rosenberg, S Halabi, B L Sanford, et al.
Pageof 5